Sebastian Szmit/LinkedIn
May 19, 2026, 14:35
Sebastian Szmit: Our Editorial on Edoxaban for Treatment of Cancer-Associated DVT Is Now Live
Sebastian Szmit, Head of Department of Cardio-Oncology, Centrum Medycznego Kształcenia Podyplomowego, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Thrombosis and Thrombolysis, adding:
”Our Editorial ‘Edoxaban for treatment of cancer-related isolated distal deep vein thrombosis: harnessing evidence, seeking equipoise’ has been published online in Journal of Thrombosis and Thrombolysis.”
Title: Edoxaban for treatment of cancer-related isolated distal deep veinthrombosis: harnessing evidence, seeking equipoise
Authors: Andrea Minghini, Sebastian Szmit, Pietro Ameri
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 5, 2026, 18:38Annie Bauzon: Clinical Significance and Causes of RBC Anisocytosis
-
Jun 5, 2026, 18:36Nandan Lad: Microclots as the Cause of Secondary Stroke After Subarachnoid Hemorrhage
-
Jun 5, 2026, 18:32George Sands: A Thoughtful Editorial on Low-Dose Rivaroxaban in Advanced CKD
-
Jun 5, 2026, 18:29Zain Khalpey: Recognizing High-Risk Coronary Hematoma Characteristics During PCI
-
Jun 5, 2026, 18:28Mirza Imail Baig: Silent but Significant – The Clinical Importance of Pulmonary Embolism
-
Jun 5, 2026, 17:26Anzila Waseem: Diet and Warfarin – A Guide to INR Stability
-
Jun 5, 2026, 17:06Lukas Mayer-Suess: How to Best Care for Patients Suffering Stroke Due to Isolated Cervical Internal Carotid Artery Occlusion
-
Jun 5, 2026, 17:02Sudhir Kumar: How Iron Deficiency Anemia Falsely Raises Diabetes Lab Results
-
Jun 5, 2026, 17:00Henning Nilius: An Explainable Machine Learning Tool for Pre-Surgery Screening